CytoSorbents Announces Resignation Of Chief Financial Officer Alexander D'Amico, Effective August 28, 2023; Ms. Kathleen Bloch Will Continue To Serve As The Company's Interim Chief Financial Officer
Portfolio Pulse from Happy Mohamed
CytoSorbents Corporation (NASDAQ:CTSO) announced the resignation of CFO Alexander D'Amico, effective August 28, 2023. The company and D'Amico have mutually agreed to terminate his employment agreement, with no severance payments or equity vesting. Kathleen Bloch will continue to serve as the Interim CFO.
September 01, 2023 | 8:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The resignation of CFO Alexander D'Amico may cause short-term uncertainty for CytoSorbents Corporation.
The resignation of a CFO can lead to uncertainty as investors may question the financial stability and future prospects of the company. This could potentially lead to a short-term decrease in the company's stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100